PPII, The float on this company is very small, This could be your chance to buy a great company before PPII flies

PPII closed @ .60 on Friday.  We have been watching this pick.  We are strongly urging members to get a starter position in PPII.

This company only has 5 million shares in the float.  If you can get stock in this company right at the start, you will be there to profit once the company becomes better known.

This stock reminds us of a lot of AWSL when we first started covering that stock.  The volume was low but we dove in.  Eventually the stock rallied hard from .84 to $4.84. That move made our members 476.19%.  We think PPII could be AWSL #2.

PPII owns 100% of Coenzyme-A Technologies, Inc. (http://www.coenzyme-a.com/).  Coenzyme- A-Technologies operates in the $15 Billion USD nutraceuticals market.  They have a cross section of products which they hope will dominate different verticals in the slace.

The company is run by CEO, Nikolaos D. Souras. Dr. Souras is an expert in the nutraceuticals field.  You get a good idea of how broad his knowledge is when you go to the company website and you see his papers published on the benefits of the Coenzyme Products.

http://www.coenzyme-a.com/research1.html

The company put out some good PRs in the last two weeks.  Things are ticking along for the company.  This could be the calm before the storm.

The last PR issued was the reason we decided to pounce on the PPII opportunity.  This excerpt from the PR shows you that the company is ready to create strong revenue flow out of the gate.

Pro Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned subsidiary Coenzyme-A Technologies, Inc. is pleased to announce they are beginning distribution negotiations with ERC Saglik Urunleri, a Mediterranean Company and also Global Pharmaceuticals, a North African Company. Both of these companies are leading international wholesale pharmaceutical distributors for the medical-optical devices and pharmaceutical equipment and nutraceutical and have a large customer base in the Mediterranean region, North Africa and the Middle East territories. Erc Saglik Urunleri is currently serving many of the over 1100 hospitals, 18,000 independent pharmacies and approximately 22,000 independent medical practices in their respective territories.

We have included the PR links for our members to review.

Pro-Pointer, Inc. Enters Negotiations With Two International Wholesale Pharmaceutical Distributors

http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=U-i0588908-U:PPII-20100219&symbol=PPII&news_region=U

UPDATE: Pro-Pointer, Inc. Introduces a Revolutionary Approach to Weight Management

http://www.stockwatch.com/newsit/newsit_newsit.aspx?bid=U-i0586995-U:PPII-20100212&symbol=PPII&news_region=U

Please remember to do your due diligence on PPII.